Selected research
Industry Research
Pain Management Drugs & Devices Industry Research Report 2026
Market perspective
The global Pain Management Drugs & Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pain Management Drugs & Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pain Management Drugs & Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pain Management Drugs & Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pain Management Drugs & Devices include Abbott, Johnson & Johnson, Medtronic Inc., Eli Lilly & Co., Pfizer, Abbvie Inc., Purdue Pharmaceuticals Lp, Novartis International Ag and Hisamitsu Pharmaceutical Co. Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pain Management Drugs & Devices market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pain Management Drugs & Devices Market by Company
Abbott
Johnson & Johnson
Medtronic Inc.
Eli Lilly & Co.
Pfizer
Abbvie Inc.
Purdue Pharmaceuticals Lp
Novartis International Ag
Hisamitsu Pharmaceutical Co. Inc.
Glaxosmithkline
Endo International
Djo Global Inc.
Astrazeneca Depomed Inc.
Pain Management Drugs & Devices Segment by Type
Pharmaceuticals
Devices
Pain Management Drugs & Devices Segment by Application
Cancer Pain
Obstetrical Pain
Musculoskeletal Pain
Migraine Headache Pain
Burn Pain
Neuropathic Pain
Dental/Facial Pain
Pain Management Drugs & Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs & Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs & Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs & Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pain Management Drugs & Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pain Management Drugs & Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceuticals
- Devices
Applications
- Cancer Pain
- Obstetrical Pain
- Musculoskeletal Pain
- Migraine Headache Pain
- Burn Pain
- Neuropathic Pain
- Dental/Facial Pain
Companies covered
- Abbott
- Johnson & Johnson
- Medtronic Inc.
- Eli Lilly & Co.
- Pfizer
- Abbvie Inc.
- Purdue Pharmaceuticals Lp
- Novartis International Ag
- Hisamitsu Pharmaceutical Co. Inc.
- Glaxosmithkline
- Endo International
- Djo Global Inc.
- Astrazeneca Depomed Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pain Management Drugs & Devices Market Size (2021-2032)
- 2.2.2 Global Pain Management Drugs & Devices Sales (2021-2032)
- 2.2.3 Global Pain Management Drugs & Devices Market Average Price (2021-2032)
- 2.3 Pain Management Drugs & Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceuticals
- 2.3.3 Devices
- 2.4 Pain Management Drugs & Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Pain
- 2.4.3 Obstetrical Pain
- 2.4.4 Musculoskeletal Pain
- 2.4.5 Migraine Headache Pain
- 2.4.6 Burn Pain
- 2.4.7 Neuropathic Pain
- 2.4.8 Dental/Facial Pain
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pain Management Drugs & Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pain Management Drugs & Devices Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Pain Management Drugs & Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Pain Management Drugs & Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Pain Management Drugs & Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pain Management Drugs & Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pain Management Drugs & Devices, Product Type & Application
- 3.8 Global Manufacturers of Pain Management Drugs & Devices, Established Date
- 3.9 Global Pain Management Drugs & Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Pain Management Drugs & Devices Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Pain Management Drugs & Devices Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Medtronic Inc.
- 4.3.1 Medtronic Inc. Company Information
- 4.3.2 Medtronic Inc. Business Overview
- 4.3.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medtronic Inc. Pain Management Drugs & Devices Product Portfolio
- 4.3.5 Medtronic Inc. Recent Developments
- 4.4 Eli Lilly & Co.
- 4.4.1 Eli Lilly & Co. Company Information
- 4.4.2 Eli Lilly & Co. Business Overview
- 4.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio
- 4.4.5 Eli Lilly & Co. Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Pain Management Drugs & Devices Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Abbvie Inc.
- 4.6.1 Abbvie Inc. Company Information
- 4.6.2 Abbvie Inc. Business Overview
- 4.6.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Abbvie Inc. Pain Management Drugs & Devices Product Portfolio
- 4.6.5 Abbvie Inc. Recent Developments
- 4.7 Purdue Pharmaceuticals Lp
- 4.7.1 Purdue Pharmaceuticals Lp Company Information
- 4.7.2 Purdue Pharmaceuticals Lp Business Overview
- 4.7.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio
- 4.7.5 Purdue Pharmaceuticals Lp Recent Developments
- 4.8 Novartis International Ag
- 4.8.1 Novartis International Ag Company Information
- 4.8.2 Novartis International Ag Business Overview
- 4.8.3 Novartis International Ag Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novartis International Ag Pain Management Drugs & Devices Product Portfolio
- 4.8.5 Novartis International Ag Recent Developments
- 4.9 Hisamitsu Pharmaceutical Co. Inc.
- 4.9.1 Hisamitsu Pharmaceutical Co. Inc. Company Information
- 4.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
- 4.9.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio
- 4.9.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments
- 4.10 Glaxosmithkline
- 4.10.1 Glaxosmithkline Company Information
- 4.10.2 Glaxosmithkline Business Overview
- 4.10.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Glaxosmithkline Pain Management Drugs & Devices Product Portfolio
- 4.10.5 Glaxosmithkline Recent Developments
- 4.11 Endo International
- 4.11.1 Endo International Company Information
- 4.11.2 Endo International Business Overview
- 4.11.3 Endo International Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Endo International Pain Management Drugs & Devices Product Portfolio
- 4.11.5 Endo International Recent Developments
- 4.12 Djo Global Inc.
- 4.12.1 Djo Global Inc. Company Information
- 4.12.2 Djo Global Inc. Business Overview
- 4.12.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Djo Global Inc. Pain Management Drugs & Devices Product Portfolio
- 4.12.5 Djo Global Inc. Recent Developments
- 4.13 Astrazeneca Depomed Inc.
- 4.13.1 Astrazeneca Depomed Inc. Company Information
- 4.13.2 Astrazeneca Depomed Inc. Business Overview
- 4.13.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio
- 4.13.5 Astrazeneca Depomed Inc. Recent Developments
5 Global Pain Management Drugs & Devices Market Scenario by Region
- 5.1 Global Pain Management Drugs & Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pain Management Drugs & Devices Sales by Region: 2021-2032
- 5.2.1 Global Pain Management Drugs & Devices Sales by Region: 2021-2026
- 5.2.2 Global Pain Management Drugs & Devices Sales by Region: 2027-2032
- 5.3 Global Pain Management Drugs & Devices Revenue by Region: 2021-2032
- 5.3.1 Global Pain Management Drugs & Devices Revenue by Region: 2021-2026
- 5.3.2 Global Pain Management Drugs & Devices Revenue by Region: 2027-2032
- 5.4 North America Pain Management Drugs & Devices Market Facts & Figures by Country
- 5.4.1 North America Pain Management Drugs & Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pain Management Drugs & Devices Sales by Country (2021-2032)
- 5.4.3 North America Pain Management Drugs & Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pain Management Drugs & Devices Market Facts & Figures by Country
- 5.5.1 Europe Pain Management Drugs & Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pain Management Drugs & Devices Sales by Country (2021-2032)
- 5.5.3 Europe Pain Management Drugs & Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pain Management Drugs & Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pain Management Drugs & Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pain Management Drugs & Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pain Management Drugs & Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pain Management Drugs & Devices Market Facts & Figures by Country
- 5.7.1 South America Pain Management Drugs & Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pain Management Drugs & Devices Sales by Country (2021-2032)
- 5.7.3 South America Pain Management Drugs & Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pain Management Drugs & Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pain Management Drugs & Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pain Management Drugs & Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pain Management Drugs & Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pain Management Drugs & Devices Sales by Type (2021-2032)
- 6.1.1 Global Pain Management Drugs & Devices Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Pain Management Drugs & Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Pain Management Drugs & Devices Revenue by Type (2021-2032)
- 6.2.1 Global Pain Management Drugs & Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pain Management Drugs & Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Pain Management Drugs & Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pain Management Drugs & Devices Sales by Application (2021-2032)
- 7.1.1 Global Pain Management Drugs & Devices Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Pain Management Drugs & Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Pain Management Drugs & Devices Revenue by Application (2021-2032)
- 7.2.1 Global Pain Management Drugs & Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pain Management Drugs & Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Pain Management Drugs & Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pain Management Drugs & Devices Value Chain Analysis
- 8.1.1 Pain Management Drugs & Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pain Management Drugs & Devices Production Mode & Process
- 8.2 Pain Management Drugs & Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pain Management Drugs & Devices Distributors
- 8.2.3 Pain Management Drugs & Devices Customers
9 Global Pain Management Drugs & Devices Analyzing Market Dynamics
- 9.1 Pain Management Drugs & Devices Industry Trends
- 9.2 Pain Management Drugs & Devices Industry Drivers
- 9.3 Pain Management Drugs & Devices Industry Opportunities and Challenges
- 9.4 Pain Management Drugs & Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst